Form 4: RenovoRx CEO Buys 5,000 Shares in Open Market

RenovoRx, Inc. CEO Shaun Bagai purchased 5,000 shares of common stock in an open market transaction.

Summary

• Shaun Bagai, the Chief Executive Officer and a Director of RenovoRx, Inc. (RNXT), acquired 5,000 shares of the company's common stock.
• The transaction occurred on December 18, 2025, through an open market purchase.
• Each share was acquired at a price of $0.9013.
• Following this transaction, Shaun Bagai directly beneficially owns a total of 340,040 shares of RenovoRx, Inc. common stock.

Sentiment

Score: 7

Explanation: The insider purchase by the CEO is generally viewed as a positive signal, indicating management's confidence in the company's valuation and future performance.

Positives

• Insider buying by the CEO and a Director, Shaun Bagai, signals confidence in the company's future prospects.
• The purchase of 5,000 shares at $0.9013 per share demonstrates a direct financial commitment from management.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Shaun Bagai, as CEO and Director, purchased 5,000 shares of RenovoRx, Inc. common stock, which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the CEO's purchase as a positive indicator of management's belief in the company's value, potentially boosting investor confidence.

Key Dates

Recommendation

The insider purchase by the CEO is a positive signal, suggesting management believes the stock is undervalued or has strong future prospects. However, a single insider transaction, while encouraging, typically warrants a 'hold' recommendation rather than a 'buy' without additional fundamental analysis or broader market context. It provides a data point for confidence but not a complete investment thesis.

Keywords

RenovoRx, RNXT, Insider Trading, Stock Purchase, CEO, Common Stock, Form 4